Heerma van Voss, M. R., Brilliant, J. D., Vesuna, F., Bol, G. M., van der Wall, E., van Diest, P. J., & Raman, V. (2017). Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer. Med Oncol.
استشهاد بنمط شيكاغوHeerma van Voss, Marise R., Justin D. Brilliant, Farhad Vesuna, Guus M. Bol, Elsken van der Wall, Paul J. van Diest, و Venu Raman. "Combination Treatment Using DDX3 and PARP Inhibitors Induces Synthetic Lethality in BRCA1-proficient Breast Cancer." Med Oncol 2017.
MLA استشهادHeerma van Voss, Marise R., et al. "Combination Treatment Using DDX3 and PARP Inhibitors Induces Synthetic Lethality in BRCA1-proficient Breast Cancer." Med Oncol 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.